Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs MadeMed

Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

Published by The GLP-1 Verdict

Pricing sources checked: CoreAge Rx: August 2026 · MadeMed: October 2026

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade B · #18

MadeMed

Publishes its price at every single dose, so the cost of the dose you titrate to is knowable on day one rather than a surprise at month four.

Visit MadeMed

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 84/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. MadeMed still earns its place — anyone who expects to titrate and wants the year-two cost visible before starting, with an oral route available without changing provider.

The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results80
97Price honesty95
96Prescriber access80
88Formulary choice88
95Cancellation fairness84
93Member support79

Price, coverage & features

MetricCoreAge RxMadeMed
Verdict Score94/10084/100
GradeAB
Semaglutide$99/mo$239/mo quarterly (from $199/mo on 6 months)
Tirzepatide$149/mo$399/mo quarterly (from $369/mo on 6 months)
CoverageAll 50 states23 states for injections (40 for tablets)
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoYes

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

MadeMed

What we like

  • One flat price at every dose, published dose by dose — semaglutide 0.25mg to 2.4mg, tirzepatide 2.5mg to 15mg
  • LegitScript verified, with board-certified physician review and US compounding pharmacies
  • Full refund minus a $39 physician-visit fee if you are not prescribed — stated before checkout, not buried in terms
  • Oral semaglutide and oral tirzepatide offered alongside the injections, with free overnight shipping and supplies included

The caveats

  • Tirzepatide at $399/mo is roughly three times the cheapest flat rate we rank, and the quoted rate is a quarterly commitment
  • Injections ship to only 23 states (tablets reach 40) — check yours before starting
  • Compounded only, with no brand-name pathway
  • Ships one vial every two months, a less flexible cadence than a monthly refill

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

Anyone who expects to titrate and wants the year-two cost visible before starting, with an oral route available without changing provider.

Visit MadeMed Read the full MadeMed review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for MadeMed does the reverse.

Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.